US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc.

0.2865

+0.031512.35%

Post-market: 0.30000.0135+4.71%19:55 EST

Volume:3.54M

Turnover:1.02M

Market Cap:33.52M

PE:-0.65

High:0.3069

Open:0.2598

Low:0.2576

Close:0.2550

52wk High:2.14

52wk Low:0.2500

Shares:117.00M

Float Shares:111.54M

Volume Ratio:1.88

T/O Rate:3.17%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4400

EPS(LYR):-0.9026

ROE:-916.17%

ROA:-130.48%

PB:7.37

PE(LYR):-0.32

Loading ...

Overview Company News Filings

Reviva Pharmaceuticals Granted Nasdaq Extension to Meet Minimum Bid Price Requirement

BRIEF-Reviva Announces Publication On Clinical Vocal Biomarker Data From The Recover Phase 3 Clinical Trial Of Brilaroxazine

Reviva Pharmaceuticals Reports Phase 3 Success for Brilaroxazine in Treating Schizophrenia Negative Symptoms

Reviva Announces Publication on Clinical Vocal Biomarker Data From the Recover Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia

THOMSON REUTERS

Reviva Pharm Holdings Is Maintained at Buy by Chardan Capital

Reviva Pharmaceuticals CEO to Present at Sachs Neuroscience Innovation Forum

Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital

BRIEF-Reviva Pharmaceuticals Recover-2 Trial Projected To Cost About $60 Million

Reviva Pharmaceuticals: Negative Symptoms/Bipolar Trial Is Projected to Cost About $30 Mln

THOMSON REUTERS

Reviva Pharmaceuticals Plans RECOVER-2 Phase 3 Trial for Schizophrenia Drug Brilaroxazine

Reviva Pharmaceuticals Holdings Inc - Recover-2 Trial Planned for H1 2026

THOMSON REUTERS

Reviva Pharmaceuticals Holdings Inc - FDA Recommends Second Phase 3 Trial for Brilaroxazine

THOMSON REUTERS

Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia

THOMSON REUTERS

Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital

Alliance Global Partners Sticks to Their Buy Rating for Reviva Pharmaceuticals Holdings (RVPH)

Reviva Pharmaceuticals Q3 net loss narrows

BRIEF-Reviva Pharmaceuticals Q3 EPS USD -0.06

Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Reviva Pharmaceuticals Holdings options imply 21.1% move in share price post-earnings

Reviva to Present Anti-Inflammatory Impacts of Brilaroxazine in Schizophrenia from the RECOVER 12-month Open Label Extension Trial at Neuroscience 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RVPH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RVPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVPH\",,,,,undefined,":{"symbol":"RVPH","market":"US","secType":"STK","nameCN":"Reviva Pharmaceuticals Holdings, Inc.","latestPrice":0.2865,"timestamp":1770411600000,"preClose":0.255,"halted":0,"volume":3535556,"hourTrading":{"tag":"盘后","latestPrice":0.3,"preClose":0.2865,"latestTime":"19:55 EST","volume":42086,"amount":12467.244,"timestamp":1770425711582,"change":0.0135,"changeRate":0.04712,"amplitude":0.052356},"delay":0,"changeRate":0.12352941176470578,"floatShares":111543325,"shares":117000000,"eps":-0.44,"marketStatus":"Market Closed","change":0.0315,"latestTime":"02-06 16:00:00 EST","open":0.2598,"high":0.3069,"low":0.2576,"amount":1019941.1547027199,"amplitude":0.193333,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.44,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.255,"preHourTrading":{"tag":"盘前","latestPrice":0.2603,"preClose":0.255,"latestTime":"09:25 EST","volume":26998,"amount":6825.7774494,"timestamp":1770387917985,"change":0.0053,"changeRate":0.020784,"amplitude":0.049804},"postHourTrading":{"tag":"盘后","latestPrice":0.3,"preClose":0.2865,"latestTime":"19:55 EST","volume":42086,"amount":12467.244,"timestamp":1770425711582,"change":0.0135,"changeRate":0.04712,"amplitude":0.052356},"volumeRatio":1.8774933739014812,"impliedVol":1.3471,"impliedVolPercentile":0.5339},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVPH\",,,,,undefined,":{"symbol":"RVPH","floatShares":111543325,"roa":"-130.48%","roe":"-916.17%","lyrEps":-0.902598,"volumeRatio":1.8774933739014812,"shares":117000000,"dividePrice":0,"high":0.3069,"amplitude":0.193333,"preClose":0.255,"low":0.2576,"week52Low":0.25,"pbRate":"7.37","week52High":2.14,"institutionHeld":0,"latestPrice":0.2865,"eps":-0.44,"divideRate":0,"volume":3535556,"delay":0,"ttmEps":-0.44,"open":0.2598,"prevYearClose":0.279,"prevWeekClose":0.2924,"prevMonthClose":0.2924,"prevQuarterClose":0.279,"fiveDayClose":0.2924,"twentyDayClose":0.366,"sixtyDayClose":0.5499},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RVPH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"RVPH","fiscalQuarterEnding":"2025/09","expectedEps":-0.11,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2025-08-14","symbol":"RVPH","fiscalQuarterEnding":"2025/06","expectedEps":-0.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2025-05-15","symbol":"RVPH","fiscalQuarterEnding":"2025/03","expectedEps":-0.21,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2025-03-31","symbol":"RVPH","fiscalQuarterEnding":"2024/12","expectedEps":-0.22,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2024-11-14","symbol":"RVPH","fiscalQuarterEnding":"2024/09","expectedEps":-0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RVPH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RVPH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":7,"updateTime":1761541200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RVPH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RVPH","date":"2026-02-06","current":-0.651136,"percent":0.771521,"low":-36.789789,"twenty":-6.089233,"median":-2.988557,"eighty":-1.224502,"high":-0.516004,"avg":-5.029892,"sd":6.216084,"marketCap":29796732},"quantilePoints":[{"date":"2021-02-12","current":-35.998611,"twenty":-37.042966,"median":-35.662361,"eighty":-33.822871,"marketCap":84008806},{"date":"2021-02-19","current":-34.21846,"twenty":-36.948025,"median":-35.444787,"eighty":-33.822871,"marketCap":79854525},{"date":"2021-02-26","current":-36.433759,"twenty":-36.810755,"median":-35.286551,"eighty":-33.427281,"marketCap":85024297},{"date":"2021-03-05","current":-30.974629,"twenty":-36.789789,"median":-35.207433,"eighty":-33.229487,"marketCap":72284500},{"date":"2021-03-12","current":-33.545958,"twenty":-36.749835,"median":-35.088756,"eighty":-33.090635,"marketCap":78285129},{"date":"2021-03-19","current":-30.143892,"twenty":-36.671112,"median":-34.811843,"eighty":-32.39875,"marketCap":70345835},{"date":"2021-03-26","current":-14.396421,"twenty":-36.591995,"median":-34.59427,"eighty":-31.647131,"marketCap":54467248},{"date":"2021-04-01","current":-13.6644,"twenty":-36.591995,"median":-34.21846,"eighty":-31.552189,"marketCap":51697727},{"date":"2021-04-09","current":-12.249158,"twenty":-36.512877,"median":-33.921768,"eighty":-30.808482,"marketCap":46343319},{"date":"2021-04-16","current":-10.760715,"twenty":-36.477274,"median":-33.624681,"eighty":-14.894196,"marketCap":40711960},{"date":"2021-04-23","current":-10.541108,"twenty":-36.441671,"median":-33.437171,"eighty":-13.762003,"marketCap":39881103},{"date":"2021-04-30","current":-14.079212,"twenty":-36.370465,"median":-33.229487,"eighty":-13.962089,"marketCap":53267122},{"date":"2021-05-07","current":-13.273989,"twenty":-36.101464,"median":-32.82381,"eighty":-13.625359,"marketCap":50220649},{"date":"2021-05-14","current":-11.785545,"twenty":-36.006523,"median":-32.39875,"eighty":-13.254468,"marketCap":44589289},{"date":"2021-05-21","current":-12.560104,"twenty":-35.998611,"median":-32.032829,"eighty":-12.556477,"marketCap":50036014},{"date":"2021-05-28","current":-21.627663,"twenty":-35.777081,"median":-31.647131,"eighty":-12.424844,"marketCap":86158685},{"date":"2021-06-04","current":-21.454642,"twenty":-35.650493,"median":-31.568013,"eighty":-12.512686,"marketCap":85469415},{"date":"2021-06-11","current":-20.892323,"twenty":-35.413139,"median":-31.350439,"eighty":-12.552849,"marketCap":83229289},{"date":"2021-06-18","current":-21.19511,"twenty":-35.23908,"median":-30.143892,"eighty":-12.593143,"marketCap":84435511},{"date":"2021-06-25","current":-21.584408,"twenty":-35.207433,"median":-22.233238,"eighty":-12.717652,"marketCap":85986367},{"date":"2021-07-02","current":-19.724429,"twenty":-35.207433,"median":-21.584408,"eighty":-12.831206,"marketCap":78576720},{"date":"2021-07-09","current":-19.767684,"twenty":-35.191609,"median":-21.541153,"eighty":-12.987371,"marketCap":78749038},{"date":"2021-07-16","current":-17.085854,"twenty":-35.136226,"median":-21.433014,"eighty":-13.215427,"marketCap":68065361},{"date":"2021-07-23","current":-16.56679,"twenty":-35.057109,"median":-21.228621,"eighty":-13.273989,"marketCap":65997552},{"date":"2021-07-30","current":-15.139364,"twenty":-34.93052,"median":-21.19511,"eighty":-13.283749,"marketCap":60311079},{"date":"2021-08-06","current":-14.793322,"twenty":-34.811843,"median":-21.022089,"eighty":-13.366711,"marketCap":58932540},{"date":"2021-08-13","current":-15.139364,"twenty":-34.732725,"median":-20.957206,"eighty":-13.547276,"marketCap":60311079},{"date":"2021-08-20","current":-9.404797,"twenty":-34.606137,"median":-20.719301,"eighty":-13.215427,"marketCap":44585323},{"date":"2021-08-27","current":-10.139106,"twenty":-34.560566,"median":-20.546281,"eighty":-12.58213,"marketCap":48066459},{"date":"2021-09-03","current":-12.229061,"twenty":-34.393389,"median":-19.940706,"eighty":-12.320198,"marketCap":57974309},{"date":"2021-09-10","current":-12.53973,"twenty":-34.178901,"median":-19.767684,"eighty":-12.23308,"marketCap":59447097},{"date":"2021-09-17","current":-12.624458,"twenty":-34.020665,"median":-19.443269,"eighty":-12.042659,"marketCap":59848767},{"date":"2021-09-24","current":-12.483245,"twenty":-33.981106,"median":-18.253748,"eighty":-11.971352,"marketCap":59179318},{"date":"2021-10-01","current":-11.946634,"twenty":-33.822871,"median":-17.79523,"eighty":-11.901446,"marketCap":56635410},{"date":"2021-10-08","current":-11.155841,"twenty":-33.783233,"median":-17.202503,"eighty":-11.778852,"marketCap":52886494},{"date":"2021-10-15","current":-10.590988,"twenty":-33.608936,"median":-16.501907,"eighty":-11.723903,"marketCap":50208697},{"date":"2021-10-22","current":-9.941407,"twenty":-33.526179,"median":-16.047726,"eighty":-11.517346,"marketCap":47129230},{"date":"2021-10-29","current":-10.254066,"twenty":-33.443105,"median":-15.64687,"eighty":-11.410024,"marketCap":48611451},{"date":"2021-11-05","current":-11.132986,"twenty":-33.427281,"median":-15.204247,"eighty":-11.214727,"marketCap":52778146},{"date":"2021-11-12","current":-11.074391,"twenty":-33.387722,"median":-15.139364,"eighty":-11.178215,"marketCap":52500367},{"date":"2021-11-19","current":-7.451852,"twenty":-33.229487,"median":-15.006439,"eighty":-11.137557,"marketCap":47399949},{"date":"2021-11-26","current":-8.309145,"twenty":-33.229487,"median":-14.793322,"eighty":-11.074391,"marketCap":52853041},{"date":"2021-12-03","current":-8.02338,"twenty":-33.090635,"median":-14.685184,"eighty":-10.760715,"marketCap":51035343},{"date":"2021-12-10","current":-8.243199,"twenty":-32.556985,"median":-14.53379,"eighty":-10.590988,"marketCap":52433572},{"date":"2021-12-17","current":-6.352759,"twenty":-32.517427,"median":-14.37202,"eighty":-10.488445,"marketCap":40408806},{"date":"2021-12-23","current":-6.418704,"twenty":-32.422485,"median":-14.152414,"eighty":-10.293745,"marketCap":40828275},{"date":"2021-12-31","current":-6.352759,"twenty":-32.272161,"median":-13.786404,"eighty":-10.250209,"marketCap":40408806},{"date":"2022-01-07","current":-6.528614,"twenty":-32.145572,"median":-13.383792,"eighty":-10.126941,"marketCap":41527389},{"date":"2022-01-14","current":-4.462318,"twenty":-31.979425,"median":-13.273989,"eighty":-9.941407,"marketCap":28384040},{"date":"2022-01-21","current":-3.802862,"twenty":-31.765807,"median":-12.861361,"eighty":-9.883869,"marketCap":24189354},{"date":"2022-01-28","current":-3.901786,"twenty":-31.647131,"median":-12.619813,"eighty":-9.483877,"marketCap":24818589},{"date":"2022-02-04","current":-4.282448,"twenty":-31.623395,"median":-12.560104,"eighty":-9.291827,"marketCap":27239914},{"date":"2022-02-11","current":-4.068326,"twenty":-31.583836,"median":-12.511488,"eighty":-8.282767,"marketCap":25877919},{"date":"2022-02-18","current":-4.401405,"twenty":-31.520542,"median":-12.426759,"eighty":-8.095921,"marketCap":27996579},{"date":"2022-02-25","current":-4.686901,"twenty":-31.441424,"median":-12.257304,"eighty":-7.997002,"marketCap":29812573},{"date":"2022-03-04","current":-4.520362,"twenty":-31.354394,"median":-12.179078,"eighty":-7.807958,"marketCap":28753243},{"date":"2022-03-11","current":-4.044534,"twenty":-31.188247,"median":-12.087848,"eighty":-7.482627,"marketCap":25726586},{"date":"2022-03-18","current":-3.08992,"twenty":-30.642334,"median":-11.993856,"eighty":-7.350736,"marketCap":26331917},{"date":"2022-03-25","current":-3.782489,"twenty":-29.938186,"median":-11.946634,"eighty":-6.537407,"marketCap":32233899},{"date":"2022-04-01","current":-4.368508,"twenty":-26.895998,"median":-11.819543,"eighty":-6.392326,"marketCap":37227883},{"date":"2022-04-08","current":-4.119894,"twenty":-22.345702,"median":-11.777179,"eighty":-6.234057,"marketCap":35109223},{"date":"2022-04-14","current":-3.871279,"twenty":-21.662268,"median":-11.748936,"eighty":-6.053806,"marketCap":32990563},{"date":"2022-04-22","current":-3.711456,"twenty":-21.619012,"median":-11.706572,"eighty":-4.920297,"marketCap":31628567},{"date":"2022-04-29","current":-3.711456,"twenty":-21.584408,"median":-11.607723,"eighty":-4.648835,"marketCap":31628567},{"date":"2022-05-06","current":-3.320776,"twenty":-21.575757,"median":-11.482848,"eighty":-4.548911,"marketCap":28299244},{"date":"2022-05-13","current":-2.654845,"twenty":-21.523851,"median":-11.410024,"eighty":-4.389294,"marketCap":22624262},{"date":"2022-05-20","current":-1.772927,"twenty":-21.454642,"median":-11.340186,"eighty":-4.351364,"marketCap":26483250},{"date":"2022-05-27","current":-1.732403,"twenty":-21.445991,"median":-11.224329,"eighty":-4.287206,"marketCap":25877919},{"date":"2022-06-03","current":-1.843844,"twenty":-21.411387,"median":-11.169687,"eighty":-4.244201,"marketCap":27542580},{"date":"2022-06-10","current":-1.519652,"twenty":-21.411387,"median":-11.155841,"eighty":-4.187282,"marketCap":22699929},{"date":"2022-06-17","current":-1.215722,"twenty":-21.228621,"median":-11.127598,"eighty":-4.1397,"marketCap":18159943},{"date":"2022-06-24","current":-1.165066,"twenty":-21.201812,"median":-11.074391,"eighty":-4.13259,"marketCap":17403278},{"date":"2022-07-01","current":-1.215722,"twenty":-21.19511,"median":-10.990862,"eighty":-4.115908,"marketCap":18159943},{"date":"2022-07-08","current":-1.154935,"twenty":-21.19511,"median":-10.745051,"eighty":-4.067654,"marketCap":17251946},{"date":"2022-07-15","current":-1.023232,"twenty":-21.169157,"median":-10.693526,"eighty":-4.011226,"marketCap":15284618},{"date":"2022-07-22","current":-0.993852,"twenty":-21.073995,"median":-10.523684,"eighty":-3.889583,"marketCap":14845753},{"date":"2022-07-29","current":-0.644231,"twenty":-21.022089,"median":-10.488445,"eighty":-3.819392,"marketCap":9623256},{"date":"2022-08-05","current":-0.653349,"twenty":-21.022089,"median":-10.363475,"eighty":-3.775385,"marketCap":9759456},{"date":"2022-08-12","current":-0.719302,"twenty":-20.944229,"median":-10.280319,"eighty":-3.704353,"marketCap":10744633},{"date":"2022-08-19","current":-0.723588,"twenty":-20.840416,"median":-10.247409,"eighty":-3.647527,"marketCap":13509298},{"date":"2022-08-26","current":-1.486026,"twenty":-20.753905,"median":-10.166174,"eighty":-3.384705,"marketCap":27743927},{"date":"2022-09-02","current":-2.583548,"twenty":-20.719301,"median":-10.016887,"eighty":-3.228434,"marketCap":48234540},{"date":"2022-09-09","current":-2.376075,"twenty":-20.684697,"median":-9.948449,"eighty":-3.125436,"marketCap":44361030},{"date":"2022-09-16","current":-2.573168,"twenty":-20.563583,"median":-9.884922,"eighty":-2.6655,"marketCap":48040746},{"date":"2022-09-23","current":-1.981887,"twenty":-20.407863,"median":-9.855363,"eighty":-2.563314,"marketCap":37001596},{"date":"2022-09-30","current":-1.740995,"twenty":-20.174284,"median":-9.517768,"eighty":-2.418502,"marketCap":32504164},{"date":"2022-10-07","current":-2.551269,"twenty":-19.923404,"median":-9.390676,"eighty":-2.402354,"marketCap":47631889},{"date":"2022-10-14","current":-3.876177,"twenty":-19.845544,"median":-9.291827,"eighty":-2.408924,"marketCap":72367763},{"date":"2022-10-21","current":-3.668134,"twenty":-19.750382,"median":-8.309145,"eighty":-2.418502,"marketCap":68483617},{"date":"2022-10-28","current":-4.160868,"twenty":-19.655221,"median":-8.199235,"eighty":-2.434865,"marketCap":77682909},{"date":"2022-11-04","current":-5.507675,"twenty":-19.464897,"median":-8.094822,"eighty":-2.452564,"marketCap":102827641},{"date":"2022-11-11","current":-5.639071,"twenty":-19.179412,"median":-8.02338,"eighty":-2.496521,"marketCap":105280785},{"date":"2022-11-18","current":-4.785688,"twenty":-18.668999,"median":-7.957435,"eighty":-2.53813,"marketCap":95263778},{"date":"2022-11-25","current":-4.087347,"twenty":-18.167237,"median":-7.825544,"eighty":-2.552364,"marketCap":81362626},{"date":"2022-12-02","current":-3.717638,"twenty":-17.81946,"median":-7.561761,"eighty":-2.560029,"marketCap":74003193},{"date":"2022-12-09","current":-3.676559,"twenty":-17.805605,"median":-7.462843,"eighty":-2.575244,"marketCap":73185478},{"date":"2022-12-16","current":-3.851144,"twenty":-17.695754,"median":-7.363925,"eighty":-2.588928,"marketCap":76660766},{"date":"2022-12-23","current":-3.337658,"twenty":-17.334112,"median":-6.594559,"eighty":-2.619329,"marketCap":66439330},{"date":"2022-12-30","current":-4.36463,"twenty":-17.202503,"median":-6.539605,"eighty":-2.654845,"marketCap":86882201},{"date":"2023-01-06","current":-4.035999,"twenty":-17.109184,"median":-6.517623,"eighty":-2.676155,"marketCap":80340483},{"date":"2023-01-13","current":-4.508406,"twenty":-16.670603,"median":-6.374741,"eighty":-2.96274,"marketCap":89744203},{"date":"2023-01-20","current":-4.539215,"twenty":-16.48893,"median":-6.352759,"eighty":-3.045864,"marketCap":90357489},{"date":"2023-01-27","current":-4.477597,"twenty":-16.307258,"median":-6.25384,"eighty":-3.054404,"marketCap":89130917},{"date":"2023-02-03","current":-4.950004,"twenty":-16.116934,"median":-6.088976,"eighty":-3.075714,"marketCap":98534638},{"date":"2023-02-10","current":-4.826767,"twenty":-15.943913,"median":-5.957085,"eighty":-3.143195,"marketCap":96081493},{"date":"2023-02-17","current":-4.878116,"twenty":-15.770892,"median":-5.639071,"eighty":-3.189366,"marketCap":97103637},{"date":"2023-02-24","current":-4.785688,"twenty":-15.657833,"median":-5.584323,"eighty":-3.196469,"marketCap":95263778},{"date":"2023-03-03","current":-4.693261,"twenty":-15.584001,"median":-5.156154,"eighty":-3.217779,"marketCap":93423920},{"date":"2023-03-10","current":-4.528945,"twenty":-15.42485,"median":-4.950004,"eighty":-3.26395,"marketCap":90153061},{"date":"2023-03-17","current":-4.056538,"twenty":-15.195596,"median":-4.90379,"eighty":-3.289788,"marketCap":80749340},{"date":"2023-03-24","current":-4.035999,"twenty":-15.165317,"median":-4.853441,"eighty":-3.299155,"marketCap":80340483},{"date":"2023-03-31","current":-3.520825,"twenty":-15.139364,"median":-4.826767,"eighty":-3.310121,"marketCap":85694386},{"date":"2023-04-06","current":-3.76451,"twenty":-15.113411,"median":-4.821632,"eighty":-3.32236,"marketCap":91625502},{"date":"2023-04-14","current":-3.924165,"twenty":-15.008966,"median":-4.795958,"eighty":-3.330487,"marketCap":95511405},{"date":"2023-04-21","current":-4.57119,"twenty":-14.989769,"median":-4.785688,"eighty":-3.337658,"marketCap":111259538},{"date":"2023-04-28","current":-5.756003,"twenty":-14.897135,"median":-4.795958,"eighty":-3.338685,"marketCap":140097028},{"date":"2023-05-05","current":-7.050053,"twenty":-14.782264,"median":-4.816497,"eighty":-3.359699,"marketCap":171593295},{"date":"2023-05-12","current":-6.655115,"twenty":-14.731787,"median":-4.826767,"eighty":-3.427325,"marketCap":161980798},{"date":"2023-05-19","current":-6.549376,"twenty":-14.69816,"median":-4.852068,"eighty":-3.434428,"marketCap":154413513},{"date":"2023-05-26","current":-4.892449,"twenty":-14.646254,"median":-4.888385,"eighty":-3.474439,"marketCap":115348431},{"date":"2023-06-02","current":-5.645134,"twenty":-14.577045,"median":-4.888385,"eighty":-3.520825,"marketCap":133094343},{"date":"2023-06-09","current":-6.257784,"twenty":-14.53379,"median":-4.934219,"eighty":-3.520825,"marketCap":147538691},{"date":"2023-06-16","current":-5.443834,"twenty":-14.445223,"median":-5.001352,"eighty":-3.520825,"marketCap":128348344},{"date":"2023-06-23","current":-5.524027,"twenty":-14.406181,"median":-5.124589,"eighty":-3.524795,"marketCap":130239029},{"date":"2023-06-30","current":-5.524027,"twenty":-14.36714,"median":-5.233783,"eighty":-3.529985,"marketCap":130239029},{"date":"2023-07-07","current":-5.197389,"twenty":-14.323219,"median":-5.28192,"eighty":-3.540999,"marketCap":122537939},{"date":"2023-07-14","current":-4.803502,"twenty":-14.196335,"median":-5.18772,"eighty":-3.580071,"marketCap":113251330},{"date":"2023-07-21","current":-4.678611,"twenty":-14.079212,"median":-5.101319,"eighty":-3.604907,"marketCap":110306795},{"date":"2023-07-28","current":-4.015727,"twenty":-14.02065,"median":-4.950004,"eighty":-3.645797,"marketCap":94678111},{"date":"2023-08-04","current":-4.126208,"twenty":-13.830325,"median":-4.9334,"eighty":-3.664235,"marketCap":97282892},{"date":"2023-08-11","current":-4.150226,"twenty":-13.688801,"median":-4.888385,"eighty":-3.667765,"marketCap":97849149},{"date":"2023-08-18","current":-2.967962,"twenty":-13.508235,"median":-4.852068,"eighty":-3.598698,"marketCap":91054069},{"date":"2023-08-25","current":-3.673038,"twenty":-13.33255,"median":-4.826767,"eighty":-3.531384,"marketCap":112685073},{"date":"2023-09-01","current":-2.886749,"twenty":-13.278869,"median":-4.821632,"eighty":-3.520825,"marketCap":88562540},{"date":"2023-09-08","current":-3.004877,"twenty":-13.273989,"median":-4.815686,"eighty":-3.427325,"marketCap":92186582},{"date":"2023-09-15","current":-4.355964,"twenty":-13.215427,"median":-4.795958,"eighty":-3.427325,"marketCap":133636569},{"date":"2023-09-22","current":-3.787474,"twenty":-12.987371,"median":-4.785688,"eighty":-3.448635,"marketCap":116195864},{"date":"2023-09-29","current":-3.72841,"twenty":-12.816129,"median":-4.775418,"eighty":-3.46714,"marketCap":114383843},{"date":"2023-10-06","current":-3.824389,"twenty":-12.689064,"median":-4.767717,"eighty":-3.487725,"marketCap":117328377},{"date":"2023-10-13","current":-3.602899,"twenty":-12.6226,"median":-4.726646,"eighty":-3.503795,"marketCap":110533298},{"date":"2023-10-20","current":-2.73909,"twenty":-12.615169,"median":-4.7193,"eighty":-3.427325,"marketCap":84032486},{"date":"2023-10-27","current":-2.798153,"twenty":-12.59629,"median":-4.7138,"eighty":-3.382057,"marketCap":85844508},{"date":"2023-11-03","current":-3.632431,"twenty":-12.564825,"median":-4.693261,"eighty":-3.346427,"marketCap":111439308},{"date":"2023-11-10","current":-4.090177,"twenty":-12.552849,"median":-4.686901,"eighty":-3.382057,"marketCap":125482473},{"date":"2023-11-17","current":-2.751979,"twenty":-12.541072,"median":-4.667587,"eighty":-3.346427,"marketCap":103624966},{"date":"2023-11-24","current":-3.451837,"twenty":-12.528433,"median":-4.652892,"eighty":-3.338685,"marketCap":129977902},{"date":"2023-12-01","current":-2.89924,"twenty":-12.480349,"median":-4.639318,"eighty":-3.328901,"marketCap":109170036},{"date":"2023-12-08","current":-3.032474,"twenty":-12.460364,"median":-4.606559,"eighty":-3.300761,"marketCap":114186910},{"date":"2023-12-15","current":-2.817457,"twenty":-12.404165,"median":-4.591736,"eighty":-3.207124,"marketCap":106090528},{"date":"2023-12-22","current":-2.854529,"twenty":-12.302492,"median":-4.569567,"eighty":-3.172537,"marketCap":107486456},{"date":"2023-12-29","current":-3.714595,"twenty":-12.268601,"median":-4.55372,"eighty":-3.177168,"marketCap":139871985},{"date":"2024-01-05","current":-4.08902,"twenty":-12.254046,"median":-4.549485,"eighty":-3.181984,"marketCap":153970858},{"date":"2024-01-12","current":-2.987988,"twenty":-12.241119,"median":-4.539215,"eighty":-3.174081,"marketCap":112511796},{"date":"2024-01-19","current":-3.017645,"twenty":-12.209068,"median":-4.528945,"eighty":-3.093399,"marketCap":113628539},{"date":"2024-01-26","current":-2.884187,"twenty":-12.123827,"median":-4.508406,"eighty":-3.078707,"marketCap":108603198},{"date":"2024-02-02","current":-2.824872,"twenty":-12.099773,"median":-4.477597,"eighty":-3.054835,"marketCap":106369713},{"date":"2024-02-09","current":-3.210418,"twenty":-12.087848,"median":-4.464787,"eighty":-3.050221,"marketCap":120887364},{"date":"2024-02-16","current":-3.180761,"twenty":-12.076551,"median":-4.457057,"eighty":-3.054404,"marketCap":119770622},{"date":"2024-02-23","current":-3.210418,"twenty":-12.031362,"median":-4.446787,"eighty":-3.054404,"marketCap":120887364},{"date":"2024-03-01","current":-2.824872,"twenty":-11.95635,"median":-4.446787,"eighty":-3.049175,"marketCap":106369713},{"date":"2024-03-08","current":-2.7878,"twenty":-11.946634,"median":-4.419222,"eighty":-3.032474,"marketCap":104973785},{"date":"2024-03-15","current":-2.14275,"twenty":-11.946634,"median":-4.398422,"eighty":-3.004877,"marketCap":80684638},{"date":"2024-03-22","current":-2.046364,"twenty":-11.890149,"median":-4.385169,"eighty":-2.980573,"marketCap":77055225},{"date":"2024-03-28","current":-2.891601,"twenty":-11.844961,"median":-4.368508,"eighty":-2.973159,"marketCap":108882384},{"date":"2024-04-05","current":-2.683999,"twenty":-11.81107,"median":-4.36463,"eighty":-2.965561,"marketCap":101065187},{"date":"2024-04-12","current":-2.810043,"twenty":-11.78952,"median":-4.353822,"eighty":-2.935079,"marketCap":105811342},{"date":"2024-04-19","current":-2.147536,"twenty":-11.778852,"median":-4.333407,"eighty":-2.904992,"marketCap":84314051},{"date":"2024-04-26","current":-2.119092,"twenty":-11.754585,"median":-4.306239,"eighty":-2.886237,"marketCap":83197308},{"date":"2024-05-03","current":-2.261312,"twenty":-11.748936,"median":-4.297739,"eighty":-2.869358,"marketCap":88781020},{"date":"2024-05-10","current":-1.521764,"twenty":-11.739182,"median":-4.282472,"eighty":-2.842666,"marketCap":59745718},{"date":"2024-05-17","current":-1.198229,"twenty":-11.723903,"median":-4.27219,"eighty":-2.830803,"marketCap":47740737},{"date":"2024-05-24","current":-1.016042,"twenty":-11.698099,"median":-4.259415,"eighty":-2.817457,"marketCap":40481912},{"date":"2024-05-31","current":-1.025273,"twenty":-11.65856,"median":-4.251663,"eighty":-2.814491,"marketCap":40849692},{"date":"2024-06-07","current":-1.077659,"twenty":-11.61902,"median":-4.239637,"eighty":-2.800839,"marketCap":42936903},{"date":"2024-06-14","current":-1.092626,"twenty":-11.586557,"median":-4.234865,"eighty":-2.746823,"marketCap":43533249},{"date":"2024-06-21","current":-0.935468,"twenty":-11.541368,"median":-4.220854,"eighty":-2.724037,"marketCap":37271617},{"date":"2024-06-28","current":-0.957919,"twenty":-11.485229,"median":-4.19562,"eighty":-2.686965,"marketCap":38166136},{"date":"2024-07-05","current":-0.875598,"twenty":-11.465542,"median":-4.178394,"eighty":-2.660172,"marketCap":34886233},{"date":"2024-07-12","current":-0.927984,"twenty":-11.437153,"median":-4.163491,"eighty":-2.613155,"marketCap":36973444},{"date":"2024-07-19","current":-0.785793,"twenty":-11.410024,"median":-4.15473,"eighty":-2.57286,"marketCap":31308158},{"date":"2024-07-26","current":-0.935468,"twenty":-11.399034,"median":-4.148966,"eighty":-2.510717,"marketCap":37271617},{"date":"2024-08-02","current":-0.755858,"twenty":-11.34912,"median":-4.1397,"eighty":-2.442602,"marketCap":30115466},{"date":"2024-08-09","current":-0.607306,"twenty":-11.310272,"median":-4.13259,"eighty":-2.400164,"marketCap":24196734},{"date":"2024-08-16","current":-0.533476,"twenty":-11.245006,"median":-4.13259,"eighty":-2.369597,"marketCap":19202337},{"date":"2024-08-23","current":-0.891083,"twenty":-11.221928,"median":-4.119894,"eighty":-2.320183,"marketCap":32074274},{"date":"2024-08-30","current":-1.029728,"twenty":-11.203798,"median":-4.115908,"eighty":-2.277153,"marketCap":37064782},{"date":"2024-09-06","current":-1.24119,"twenty":-11.169687,"median":-4.107887,"eighty":-2.255628,"marketCap":44676300},{"date":"2024-09-13","current":-1.10328,"twenty":-11.155841,"median":-4.08902,"eighty":-2.189931,"marketCap":39712267},{"date":"2024-09-20","current":-1.176832,"twenty":-11.155841,"median":-4.080728,"eighty":-2.17562,"marketCap":42359751},{"date":"2024-09-27","current":-1.24119,"twenty":-11.155841,"median":-4.068326,"eighty":-2.14275,"marketCap":44676300},{"date":"2024-10-04","current":-1.14925,"twenty":-11.132986,"median":-4.066726,"eighty":-2.119092,"marketCap":41366945},{"date":"2024-10-11","current":-1.121668,"twenty":-11.127598,"median":-4.060645,"eighty":-2.062203,"marketCap":40374138},{"date":"2024-10-18","current":-1.319263,"twenty":-11.077924,"median":-4.0549,"eighty":-1.991093,"marketCap":47486502},{"date":"2024-10-25","current":-1.059126,"twenty":-11.074391,"median":-4.04957,"eighty":-1.90463,"marketCap":38122966},{"date":"2024-11-01","current":-0.908154,"twenty":-11.074391,"median":-4.04317,"eighty":-1.823582,"marketCap":32688772},{"date":"2024-11-08","current":-0.855198,"twenty":-11.053819,"median":-4.035999,"eighty":-1.772927,"marketCap":30782623},{"date":"2024-11-15","current":-1.139537,"twenty":-10.927905,"median":-4.03547,"eighty":-1.752665,"marketCap":37621348},{"date":"2024-11-22","current":-1.154731,"twenty":-10.760715,"median":-4.020743,"eighty":-1.712141,"marketCap":38122966},{"date":"2024-11-29","current":-1.256023,"twenty":-10.735653,"median":-4.015727,"eighty":-1.661486,"marketCap":41467086},{"date":"2024-12-06","current":-1.671321,"twenty":-10.724136,"median":-3.986815,"eighty":-1.532024,"marketCap":55177978},{"date":"2024-12-13","current":-2.643726,"twenty":-10.699385,"median":-3.967692,"eighty":-1.603687,"marketCap":87281529},{"date":"2024-12-20","current":-1.890562,"twenty":-10.611496,"median":-3.937949,"eighty":-1.603687,"marketCap":62416126},{"date":"2024-12-27","current":-2.539561,"twenty":-10.56106,"median":-3.926664,"eighty":-1.620962,"marketCap":83842558},{"date":"2025-01-03","current":-2.680648,"twenty":-10.527169,"median":-3.916729,"eighty":-1.641106,"marketCap":88500478},{"date":"2025-01-10","current":-2.65243,"twenty":-10.503469,"median":-3.904644,"eighty":-1.67138,"marketCap":87568894},{"date":"2025-01-17","current":-2.497235,"twenty":-10.491535,"median":-3.898957,"eighty":-1.673643,"marketCap":82445182},{"date":"2025-01-24","current":-2.694756,"twenty":-10.488445,"median":-3.896247,"eighty":-1.681748,"marketCap":88966270},{"date":"2025-01-31","current":-2.666539,"twenty":-10.451304,"median":-3.886726,"eighty":-1.691879,"marketCap":88034686},{"date":"2025-02-07","current":-2.934604,"twenty":-10.42985,"median":-3.871622,"eighty":-1.712141,"marketCap":96884733},{"date":"2025-02-14","current":-2.539561,"twenty":-10.297101,"median":-3.861359,"eighty":-1.732403,"marketCap":83842558},{"date":"2025-02-21","current":-2.215061,"twenty":-10.283675,"median":-3.851776,"eighty":-1.739277,"marketCap":73129342},{"date":"2025-02-28","current":-2.031649,"twenty":-10.280319,"median":-3.835763,"eighty":-1.748873,"marketCap":67074046},{"date":"2025-03-07","current":-1.622497,"twenty":-10.259317,"median":-3.831899,"eighty":-1.739277,"marketCap":53566078},{"date":"2025-03-14","current":-1.566063,"twenty":-10.252474,"median":-3.824389,"eighty":-1.679722,"marketCap":51702910},{"date":"2025-03-21","current":-1.467302,"twenty":-10.244609,"median":-3.820882,"eighty":-1.636606,"marketCap":48442366},{"date":"2025-03-28","current":-1.424976,"twenty":-10.213028,"median":-3.806524,"eighty":-1.620962,"marketCap":47044990},{"date":"2025-04-04","current":-0.82798,"twenty":-10.174059,"median":-3.788596,"eighty":-1.551954,"marketCap":24772172},{"date":"2025-04-11","current":-1.054034,"twenty":-10.14452,"median":-3.782489,"eighty":-1.532418,"marketCap":31535443},{"date":"2025-04-17","current":-1.222286,"twenty":-10.102612,"median":-3.781324,"eighty":-1.515642,"marketCap":36569336},{"date":"2025-04-25","current":-1.336016,"twenty":-10.004607,"median":-3.774539,"eighty":-1.485586,"marketCap":39972004},{"date":"2025-05-02","current":-1.354294,"twenty":-9.955491,"median":-3.76473,"eighty":-1.4592,"marketCap":40518861},{"date":"2025-05-09","current":-1.280557,"twenty":-9.947041,"median":-3.732101,"eighty":-1.401037,"marketCap":38312736},{"date":"2025-05-16","current":-1.325358,"twenty":-9.941407,"median":-3.721027,"eighty":-1.361824,"marketCap":38326758},{"date":"2025-05-23","current":-1.697105,"twenty":-9.907516,"median":-3.714344,"eighty":-1.367323,"marketCap":49076946},{"date":"2025-05-30","current":-1.440115,"twenty":-9.884922,"median":-3.711456,"eighty":-1.378197,"marketCap":41645294},{"date":"2025-06-06","current":-1.293033,"twenty":-9.883869,"median":-3.693698,"eighty":-1.361137,"marketCap":37391959},{"date":"2025-06-13","current":-1.260707,"twenty":-9.860748,"median":-3.676644,"eighty":-1.355004,"marketCap":36457160},{"date":"2025-06-20","current":-1.08938,"twenty":-9.81714,"median":-3.67594,"eighty":-1.336382,"marketCap":31502725},{"date":"2025-06-27","current":-0.578632,"twenty":-9.721115,"median":-3.668134,"eighty":-1.325843,"marketCap":16732901},{"date":"2025-07-03","current":-0.846576,"twenty":-9.517768,"median":-3.666289,"eighty":-1.318247,"marketCap":24481300},{"date":"2025-07-11","current":-0.921827,"twenty":-9.43304,"median":-3.644225,"eighty":-1.300952,"marketCap":26657416},{"date":"2025-07-18","current":-0.952868,"twenty":-9.404797,"median":-3.604907,"eighty":-1.280557,"marketCap":27555063},{"date":"2025-07-25","current":-1.011423,"twenty":-9.376555,"median":-3.595516,"eighty":-1.276282,"marketCap":29248353},{"date":"2025-08-01","current":-1.100313,"twenty":-9.291827,"median":-3.565984,"eighty":-1.256023,"marketCap":31818890},{"date":"2025-08-08","current":-1.00813,"twenty":-9.291827,"median":-3.529285,"eighty":-1.24119,"marketCap":29153148},{"date":"2025-08-15","current":-1.096315,"twenty":-8.463018,"median":-3.520825,"eighty":-1.231996,"marketCap":31703284},{"date":"2025-08-22","current":-1.304302,"twenty":-8.309145,"median":-3.492144,"eighty":-1.23323,"marketCap":35361878},{"date":"2025-08-29","current":-1.154558,"twenty":-8.309145,"median":-3.462842,"eighty":-1.231996,"marketCap":31302063},{"date":"2025-09-05","current":-1.120696,"twenty":-8.256388,"median":-3.451837,"eighty":-1.226256,"marketCap":30384014},{"date":"2025-09-12","current":-1.111416,"twenty":-8.208028,"median":-3.433795,"eighty":-1.222699,"marketCap":30132400},{"date":"2025-09-19","current":-1.05197,"twenty":-8.146479,"median":-3.376139,"eighty":-1.215112,"marketCap":28520715},{"date":"2025-09-26","current":-0.75445,"twenty":-8.106912,"median":-3.340225,"eighty":-1.205591,"marketCap":20454450},{"date":"2025-10-03","current":-1.733318,"twenty":-8.091524,"median":-3.329729,"eighty":-1.205591,"marketCap":46993246},{"date":"2025-10-10","current":-2.78937,"twenty":-8.089326,"median":-3.314178,"eighty":-1.205591,"marketCap":75624638},{"date":"2025-10-17","current":-2.087941,"twenty":-8.036569,"median":-3.303018,"eighty":-1.208221,"marketCap":56607691},{"date":"2025-10-24","current":-2.016519,"twenty":-7.98821,"median":-3.29092,"eighty":-1.211731,"marketCap":54671315},{"date":"2025-10-31","current":-2.147282,"twenty":-7.979417,"median":-3.254905,"eighty":-1.213319,"marketCap":58216521},{"date":"2025-11-07","current":-1.777024,"twenty":-7.944246,"median":-3.243783,"eighty":-1.215112,"marketCap":48178193},{"date":"2025-11-14","current":-2.276799,"twenty":-7.917867,"median":-3.210418,"eighty":-1.215679,"marketCap":61727940},{"date":"2025-11-21","current":-2.426896,"twenty":-7.772787,"median":-3.196469,"eighty":-1.215722,"marketCap":55228137},{"date":"2025-11-28","current":-2.844018,"twenty":-7.724427,"median":-3.187534,"eighty":-1.21966,"marketCap":64720473},{"date":"2025-12-05","current":-2.989126,"twenty":-7.62331,"median":-3.180761,"eighty":-1.222596,"marketCap":68022655},{"date":"2025-12-12","current":-3.432541,"twenty":-7.522194,"median":-3.182614,"eighty":-1.224502,"marketCap":78113296},{"date":"2025-12-19","current":-2.956768,"twenty":-7.350736,"median":-3.174853,"eighty":-1.224502,"marketCap":67286280},{"date":"2025-12-26","current":-1.405577,"twenty":-7.050053,"median":-3.13458,"eighty":-1.224502,"marketCap":31986296},{"date":"2026-01-02","current":-1.410633,"twenty":-6.797472,"median":-3.099521,"eighty":-1.224502,"marketCap":32101354},{"date":"2026-01-09","current":-1.879318,"twenty":-6.55207,"median":-3.078707,"eighty":-1.224502,"marketCap":42767075},{"date":"2026-01-16","current":-1.799216,"twenty":-6.453875,"median":-3.054404,"eighty":-1.224502,"marketCap":40944216},{"date":"2026-01-23","current":-1.728356,"twenty":-6.352759,"median":-3.034275,"eighty":-1.224502,"marketCap":39331687},{"date":"2026-01-30","current":-1.533749,"twenty":-6.244095,"median":-3.008929,"eighty":-1.224502,"marketCap":34903074},{"date":"2026-02-06","current":-1.309361,"twenty":-6.089233,"median":-2.988557,"eighty":-1.224502,"marketCap":29796732}],"updateTime":1770567832638},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RVPH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606174292","title":"Reviva Pharmaceuticals Granted Nasdaq Extension to Meet Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2606174292","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606174292?lang=en_us&edition=fundamental","pubTime":"2026-01-26 15:37","pubTimestamp":1769413029,"startTime":"0","endTime":"0","summary":"Reviva Pharmaceuticals Holdings Inc. has been notified by the Nasdaq Hearings Panel that it was granted an exception to meet the $1.00 minimum bid price requirement for continued listing on the Nasdaq Stock Market. The company now has until March 27, 2026, to regain compliance with this listing rule. Reviva is required to promptly inform the Panel of any significant events that may affect its compliance status during this exception period. The company has expressed its intention to take all necessary actions to address the bid price deficiency and maintain its Nasdaq listing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reviva Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDLbHhbMq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2601362325","title":"BRIEF-Reviva Announces Publication On Clinical Vocal Biomarker Data From The Recover Phase 3 Clinical Trial Of Brilaroxazine","url":"https://stock-news.laohu8.com/highlight/detail?id=2601362325","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601362325?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:22","pubTimestamp":1767878556,"startTime":"0","endTime":"0","summary":"BRIEF-Reviva Announces Publication On Clinical Vocal Biomarker Data From The Recover Phase 3 Clinical Trial Of Brilaroxazine Jan 8 (Reuters) - Reviva Pharmaceuticals Holdings Inc RVPH.O:REVIVA ANNOUNC","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA97L1RY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RVPH"],"gpt_icon":1},{"id":"2601364555","title":"Reviva Pharmaceuticals Reports Phase 3 Success for Brilaroxazine in Treating Schizophrenia Negative Symptoms","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364555","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601364555?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:02","pubTimestamp":1767877358,"startTime":"0","endTime":"0","summary":"Reviva Pharmaceuticals Holdings Inc. has announced the publication of new clinical vocal biomarker data from the RECOVER Phase 3 clinical trial evaluating brilaroxazine for the treatment of negative symptoms in schizophrenia. The findings, published in the peer-reviewed journal Biological Psychiatry, indicate that speech latency can serve as an objective biomarker to assess treatment response and may help reduce sample sizes and enhance outcomes in clinical trials for schizophrenia. The results reinforce brilaroxazine’s therapeutic effect on negative symptoms and other symptom domains and support its efficacy as assessed by clinicians. The publication is currently available, and the company highlights the potential of this approach to improve patient stratification and mitigate placebo responses in future schizophrenia clinical trials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and time","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL4yrw1k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BKPKM429.USD","BK4007","BK4588","BK4585","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","LU2210150020.SGD","RVPH","SG9999014013.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014039.USD","BK4112","SG9999014021.USD","SG9999014005.SGD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2601336480","title":"Reviva Announces Publication on Clinical Vocal Biomarker Data From the Recover Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2601336480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601336480?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:00","pubTimestamp":1767877205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA97L1RY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2601884914","title":"Reviva Pharm Holdings Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2601884914","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601884914?lang=en_us&edition=fundamental","pubTime":"2026-01-05 21:36","pubTimestamp":1767620160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RVPH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 05, 2026 08:36 ET (13:36 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2595780257","title":"Reviva Pharmaceuticals CEO to Present at Sachs Neuroscience Innovation Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2595780257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595780257?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:00","pubTimestamp":1767013231,"startTime":"0","endTime":"0","summary":"Reviva Pharmaceuticals Holdings Inc. will present at the Sachs 9th Annual Neuroscience Innovation Forum on January 11, 2026. Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva, is scheduled to deliver a corporate presentation at 1:20 PM PT at the Marines' Memorial Club in San Francisco, CA. The company will highlight its late-stage pipeline focused on central nervous system, inflammatory, and cardiometabolic diseases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reviva Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via GlobeNewswire  on December 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL6wQ7vn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BGHQF748.EUR","SG9999014013.SGD","BK4588","BK4585","BK4112","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","RVPH","SG9999014005.SGD","LU2210149790.SGD","NDAQ","LU2210150020.SGD","IE00BKPKM429.USD","LU0314104364.USD","LU2095319765.USD","SG9999014021.USD","BK4007"],"gpt_icon":0},{"id":"2593413532","title":"Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2593413532","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593413532?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:46","pubTimestamp":1766497560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RVPH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 23, 2025 08:46 ET (13:46 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2593046490","title":"BRIEF-Reviva Pharmaceuticals Recover-2 Trial Projected To Cost About $60 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2593046490","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593046490?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:10","pubTimestamp":1766495431,"startTime":"0","endTime":"0","summary":"BRIEF-Reviva Pharmaceuticals Recover-2 Trial Projected To Cost About $60 MillionDec 23  - Reviva Pharmaceuticals Holdings Inc RVPH.O:REVIVA PHARMACEUTICALS: RECOVER-2 TRIAL PROJECTED TO COST ABOUT $60 MILLIONREVIVA PHARMACEUTICALS: MAY INITIATE PHASE 3 TRIAL OF BRILAROXAZINE FOR NEGATIVE SYMPTOMS OR BIPOLAR DISORDER IN Q2 2026REVIVA PHARMACEUTICALS: NEGATIVE SYMPTOMS/BIPOLAR TRIAL IS PROJECTED TO COST ABOUT $30 MILLIONSource text: [ID:n0001437749-25-038602]Further company coverage: RVPH.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nFWN3XT0M9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH","BK4007"],"gpt_icon":1},{"id":"2593907104","title":"Reviva Pharmaceuticals: Negative Symptoms/Bipolar Trial Is Projected to Cost About $30 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2593907104","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593907104?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:06","pubTimestamp":1766495215,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nFWN3XT0M9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2593902194","title":"Reviva Pharmaceuticals Plans RECOVER-2 Phase 3 Trial for Schizophrenia Drug Brilaroxazine","url":"https://stock-news.laohu8.com/highlight/detail?id=2593902194","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593902194?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:01","pubTimestamp":1766494896,"startTime":"0","endTime":"0","summary":"Reviva Pharmaceuticals Holdings Inc. announced plans to initiate the RECOVER-2 Phase 3 registrational trial for brilaroxazine, a novel serotonin-dopamine and neuroinflammatory signaling modulator for the treatment of schizophrenia. The initiation of the trial is expected in the first half of 2026, pending sufficient financing. This decision follows written feedback from the U.S. Food and Drug Administration  after a pre-New Drug Application  meeting, in which the FDA recommended a second Phase 3 trial to generate additional efficacy and safety data prior to NDA submission. The RECOVER-2 trial will be similar in design to the previously completed RECOVER Phase 3 trial. No new clinical results were presented at this time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financia","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL41CVtb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","SG9999014013.SGD","LU0314104364.USD","LU2210150020.SGD","RVPH","SG9999014039.USD","IE00B3QW5Z07.USD","BK4112","LU2210149790.SGD","SG9999014021.USD","BK4007","NDAQ","BK4588","SG9999014005.SGD","IE00B64PRP62.GBP","BK4585","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2593907324","title":"Reviva Pharmaceuticals Holdings Inc - Recover-2 Trial Planned for H1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2593907324","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593907324?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:00","pubTimestamp":1766494804,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nTUA62CL5T:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2593490734","title":"Reviva Pharmaceuticals Holdings Inc - FDA Recommends Second Phase 3 Trial for Brilaroxazine","url":"https://stock-news.laohu8.com/highlight/detail?id=2593490734","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593490734?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:00","pubTimestamp":1766494804,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nTUA62CL5T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2593171490","title":"Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2593171490","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593171490?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:00","pubTimestamp":1766494804,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nTUA62CL5T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2584452944","title":"Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2584452944","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584452944?lang=en_us&edition=fundamental","pubTime":"2025-11-19 21:53","pubTimestamp":1763560380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RVPH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 19, 2025 08:53 ET (13:53 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2584620740","title":"Alliance Global Partners Sticks to Their Buy Rating for Reviva Pharmaceuticals Holdings (RVPH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584620740","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584620740?lang=en_us&edition=fundamental","pubTime":"2025-11-18 00:55","pubTimestamp":1763398541,"startTime":"0","endTime":"0","summary":"Alliance Global Partners analyst James Molloy reiterated a Buy rating on Reviva Pharmaceuticals Holdings on November 14 and set a price target of $...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alliance-global-partners-sticks-to-their-buy-rating-for-reviva-pharmaceuticals-holdings-rvph-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alliance-global-partners-sticks-to-their-buy-rating-for-reviva-pharmaceuticals-holdings-rvph-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVPH"],"gpt_icon":0},{"id":"2583512694","title":"Reviva Pharmaceuticals Q3 net loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2583512694","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583512694?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:21","pubTimestamp":1763068870,"startTime":"0","endTime":"0","summary":"Reviva Pharmaceuticals Q3 net loss narrowsOverviewReviva reports Q3 net loss of $4 mln, improved from $8.4 mln loss last yearCompany plans pre-NDA meeting with FDA for brilaroxazine in Q4 2025European","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL1N3WP18L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2583511027","title":"BRIEF-Reviva Pharmaceuticals Q3 EPS USD -0.06","url":"https://stock-news.laohu8.com/highlight/detail?id=2583511027","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583511027?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067948,"startTime":"0","endTime":"0","summary":"BRIEF-Reviva Pharmaceuticals Q3 EPS USD -0.06\n\n\nNov 13 (Reuters) - Reviva Pharmaceuticals Q3 net income USD -4 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX579168:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2583985514","title":"Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2583985514","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583985514?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067900,"startTime":"0","endTime":"0","summary":"– Pre-NDA meeting with FDA to discuss brilaroxazine’s path to approval for schizophrenia planned in Q4 2025 – – Potential NDA submission for schizophrenia indication targeted for Q2 2026 – – European ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/13/3187825/0/en/Reviva-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4135","CNS","RVPH"],"gpt_icon":0},{"id":"2583116745","title":"Reviva Pharmaceuticals Holdings options imply 21.1% move in share price post-earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2583116745","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583116745?lang=en_us&edition=fundamental","pubTime":"2025-11-14 04:45","pubTimestamp":1763066738,"startTime":"0","endTime":"0","summary":"Pre-earnings options volume in Reviva Pharmaceuticals (RVPH) Holdings is normal with calls leading puts 25:1. Implied volatility suggests the marke...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/reviva-pharmaceuticals-holdings-options-imply-21-1-move-in-share-price-post-earnings-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/reviva-pharmaceuticals-holdings-options-imply-21-1-move-in-share-price-post-earnings-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2582220371","title":"Reviva to Present Anti-Inflammatory Impacts of Brilaroxazine in Schizophrenia from the RECOVER 12-month Open Label Extension Trial at Neuroscience 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2582220371","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582220371?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:00","pubTimestamp":1762952400,"startTime":"0","endTime":"0","summary":"CUPERTINO, Calif., Nov.  12, 2025  (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that s","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/12/3186179/0/en/Reviva-to-Present-Anti-Inflammatory-Impacts-of-Brilaroxazine-in-Schizophrenia-from-the-RECOVER-12-month-Open-Label-Extension-Trial-at-Neuroscience-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","BK4135","RVPH","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":53,"code":"91000000","status":"200"}]}}